Cite
MLA Citation
Birk Poller et al.. “Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes.” Pulmonary pharmacology & therapeutics, vol. 57, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100088116735.0x000018